About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us

Sources close to French President Macron said that using tariffs as a threat to change French foreign policy is unacceptable and ineffective, in response to Trump's comments on wine tariffs.

2026-01-20

Sources close to French President Macron said that using tariffs as a threat to change French foreign policy is unacceptable and ineffective, in response to Trump's comments on wine tariffs.

Other News
2026-01-20

Indonesia's Ministry of Finance: The government will not use central bank funds to finance government projects.

Indonesia's Ministry of Finance: The government will not use central bank funds to finance government projects.
2026-01-20

Individual Stock News: 1. China Pacific Insurance (02601.HK): Pacific Life Insurance's premium income in 2025 was RMB 258.115 billion, a year-on-year increase of 8.1%. 2. CICC Wealth Management achieved revenue of RMB 8.349 billion in 2025, a year-

Individual Stock News: 1. China Pacific Insurance (02601.HK): Pacific Life Insurance's premium income in 2025 was RMB 258.115 billion, a year-on-year increase of 8.1%. 2. CICC Wealth Management achieved revenue of RMB 8.349 billion in 2025, a year-on-year increase of 25.42%; net profit was RMB 1.76 billion, a year-on-year increase of 47.4%. 3. XPeng Motors (09868.HK): The first robot of our ET1 version, developed using automotive standards, has been successfully deployed. 4. Mingming is Busy (01768.HK): Plans to issue over 14 million shares in its Hong Kong IPO, with a maximum price of HKD 236.6. 5. Luoyang Molybdenum (03993.HK): Plans to issue US$1.2 billion in zero-coupon guaranteed convertible bonds maturing in 2027. 6. Pop Mart (09992.HK): On January 19, 2026, it will repurchase 1.4 million shares for HK$251 million, at a repurchase price of HK$177.7-181.2 per share. 7. Dexiang Real Estate (00199.HK) will be temporarily suspended from trading on January 20 pending the release of inside information. 8. Insilicon (03696.HK) has entered into a global strategic cooperation agreement with Hengtai Biotechnology worth over HK$500 million to jointly develop a novel blood-brain barrier-penetrating NLRP3 inhibitor. 9. A subsidiary of China Duty Free Group (01880.HK) plans to acquire all the issued share capital of DFS Cotai Limitada.
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2026 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1905-1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.

Web Design by YSD